alexa Novel Automated Patch-clamp Assays on Stem Cell-derived
ISSN: 2161-0398

Journal of Physical Chemistry & Biophysics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Novel Automated Patch-clamp Assays on Stem Cell-derived Cardiomyocytes: Will they Standardize In Vitro Pharmacology and Arrhythmia Research?

Amuzescu B*, Scheel O and Knott T
Cytocentrics Bioscience GmbH, Rostock, Germany
Corresponding Author : Amuzescu B
Cytocentrics Bioscience GmbH
Joachim Jungius Str. 9, Rostock 18059, Germany
Tel: +49 381 440 388-0
Fax: +49 381 440 388-47
E-mail: [email protected]
Received July 21, 2014; Accepted August 15, 2014; Published August 22, 2014
Citation: Amuzescu B, Scheel O, Knott T (2014) Novel Automated Patch- Clamp Assays on Stem Cell-Derived Cardiomyocytes: Will they Standardize In Vitro Pharmacology and Arrhythmia Research?. J Phys Chem Biophys 4:153. doi:10.4172/2161-0398.1000153
Copyright: © 2014 Amuzescu B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Recent progress in embryonic stem cell and human induced pluripotent stem cell technology allowed effective generation of cultured cardiomyocyte preparations with over 99% purity, rendering them suitable for automated patchclamp approaches. Compared to current high-throughput drug screening methods, such as fluorescence assays using calcium-sensitive or transmembrane potential-sensitive dyes, or field potential recordings and activation mapping using multi-electrode arrays, patch-clamp experiments offer the possibility to combine action potential recordings in current-clamp mode with detailed characterization of drug effects on multiple ion current components with carefully designed voltage-clamp protocols, leading to an in-depth understanding of arrhythmogenesis conditions and mechanisms, especially when combined with cellular electrophysiology computerized models. The recently issued Comprehensive in vitro ProArrhythmia Assay (CiPA) guidelines emphasize the importance of pharmacological tests on multiple cardiac ion channels, including at least Nav1.5 (early and late), Cav1.2, hERG1, Kv7.1/minK, and Kir2.1, via voltage-clamp protocols, instead of simple hERG screening, combined with computer modeling, in order to determine the proarrhythmic liability of a drug candidate. In addition, patch-clamp assays on patient-specific induced pluripotent stem cell-derived cardiomyocytes will enhance current molecular diagnosis methods in cardiac channelopathies by identification of the faulty current component and individualized screening of drug sensitivity of mutant channels, a step forward for personalized medicine approaches.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version